LabCentral co-founder issues ‘call to action’ to biotechs on drug pricing

LabCentral co-founder and industry veteran Johannes Fruehauf is calling for startups and small biotechs to get off the lab bench and get involved in the drug pricing conversation. “This is a call to action…. Hopefully, my speaking up will help others to reflect on what role they play in this continuum," he said. Read More

Read More

Headcount at GateHouse’s New England dailies has shrunk 20% this year

Even as top executives at GateHouse Media’s parent company have been negotiating the terms of a merger with Gannett Co., GateHouse has also been cutting headcount: 20% of newsroom employees at its 10 daily newspapers in New England have been affected. The company called the moves a "reallocation" of resources, not a reduction. Read More

Read More